Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active specific immunotherapy of human solid tumors.

F E Rosato, E Miller, E F Rosato

    Virginia Medical
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

    Journal of surgical oncology·2007
    Same author

    Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma.

    Gastrointestinal endoscopy·2001
    Same author

    Long term survival after pancreatic resection for pancreatic adenocarcinoma.

    The American journal of gastroenterology·2001
    Same author

    Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

    Cancer research·2001
    Same author

    The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.

    Cancer·2001
    Same author

    Crohn's disease of the colon.

    The Surgical clinics of North America·2001

    Enzyme altered cells show promise for treating human solid tumors when other options fail. This active immunotherapy approach appears feasible for patients with untreatable lesions.

    Area of Science:

    • Oncology
    • Immunotherapy
    • Cellular Therapy

    Background:

    • Solid tumors represent a significant challenge in cancer treatment.
    • Current therapeutic options for advanced or untreatable solid tumors are limited.
    • Active specific immunotherapy offers a potential alternative treatment strategy.

    Purpose of the Study:

    • To investigate the feasibility of using enzyme altered cells for active specific immunotherapy.
    • To evaluate this approach in patients with otherwise untreatable human solid tumors.

    Main Methods:

    • A limited study was conducted involving patients with specific types of solid tumors.
    • The core method involved the administration of enzyme altered cells as an immunotherapy agent.

    Related Experiment Videos

    Main Results:

    • The study suggests that using enzyme altered cells is a feasible approach.
    • Preliminary findings indicate potential for active specific immunotherapy in human solid tumors.

    Conclusions:

    • Enzyme altered cells demonstrate feasibility for active specific immunotherapy.
    • This approach may offer a viable treatment option for patients with untreatable solid tumors.